| (210) | Number of the EPO application | 18706072 |
| (220) | Filing date of the EPO application | 2018.02.05 |
| (80) | EPO patent specification publication (B) | EPB nr. 16/2021, 2021.04.21 |
| (110) | EPO patent number | 3577110 |
| (21) | Number of the application | e 2019 1354 |
| (71) | Name(s) of applicant(s), code of the country | Gilead Sciences, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | BACON Elizabeth M., US;
CHIN Elbert, US;
COTTELL Jeromy J., US;
KATANA Ashley Anne, US;
KATO Darryl, US;
LINK John O., US;
SHAPIRO Nathan, US;
TREJO MARTIN Teresa Alejandra, US;
YANG Zheng-Yu, US; |
| (73) | Name(s) of owner(s), code of the country | GILEAD Sciences Inc., US; |
| (54) | Title of the invention | 8-OXETAN-3-YL-3,8-DIAZABICYCLO[3.2.1]OCTAN-3-YL SUBSTITUTED COMPOUNDS AS HIV INHIBITORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 405/14 (2006.01.01); C07D 401/12 (2006.01.01); C07D 403/12 (2006.01.01); C07D 487/08 (2006.01.01); C07D 491/04 (2006.01.01); C07D 471/08 (2006.01.01); C07D 487/10 (2006.01.01); C07C 275/16 (2006.01.01); C07C 243/28 (2006.01.01); A61K 31/52 (2006.01.01); A61K 31/55 (2006.01.01); A61K 31/553 (2006.01.01); A61K 31/685 (2006.01.01); A61K 31/688 (2006.01.01); A61P 31/18 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.01.31 |
| (30) | Priority | 201762455348 P, 2017.02.06, US |
| (86) | International application | PCT/US2018/016893, 2018.02.05 |
| (87) | International publication | WO 2018/145021, 2018.08.09 |